コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 unfavorable life experiences (e.g., frequent incarcerations).
2 ering posttreatment arrest rates and days of incarceration.
3 ss is a risk factor for multiple episodes of incarceration.
4 Inmates often lack health care before incarceration.
5 ropositivity was associated with tattoos and incarceration.
6 ry of reported frequency of injection and of incarceration.
7 (5) have fewer episodes of homelessness and incarceration.
8 sing, and 57.9% (50.5-65.2) had a history of incarceration.
9 e, and 38 percent of those with a history of incarceration.
10 , foreign birth, homelessness, or history of incarceration.
11 parents had histories of substance abuse or incarceration.
12 n is a cornerstone of efforts to reduce mass incarceration.
13 e mortality, homelessness, violent crime and incarceration.
14 s resulted in extraordinarily high levels of incarceration.
15 cases in people who inject drugs are due to incarceration.
16 icipants at 1 month after their release from incarceration.
17 longer following sustained treatment versus incarceration.
18 drugs (PWID), many of whom have a history of incarceration.
19 e to women who did not have a parent undergo incarceration.
20 the relation between depression and parental incarceration.
21 kely than those without to have had previous incarcerations.
22 9), receipt of antiretroviral therapy during incarceration (1.39; 1.11-1.74), and two or more medical
23 atient, >1 sex partner, illicit drug use, or incarceration (21% of cases versus 4% of controls expose
25 men receiving 9H-SAT, men with a history of incarceration, alcohol abuse, use ever of intravenous dr
26 0 adults who had experienced at least 1 jail incarceration and 1 homeless shelter stay in 2001-2003 i
27 d States has experienced an enormous rise in incarceration and accompanying increases in returning pr
28 f deaths unlikely to occur in the context of incarceration and compassionate releases of moribund pat
29 me populations experience both high rates of incarceration and high rates of sexually transmitted inf
30 interventions to reduce recurrent cycles of incarceration and homelessness are needed to augment beh
31 aracterized by sporadic experiences of brief incarceration and homelessness, whereas the rest had the
32 assembly (supramolecular wrapping, nanoscale incarceration and nanostructure templating) or higher-or
33 on correlation coefficients between rates of incarceration and of reportable STIs in the 100 counties
34 nted to remain on methadone treatment during incarceration and on release, to either continuation of
37 rsonality disorder are especially at risk of incarceration and readmission into compulsory treatment
39 erated populations, to examine the impact of incarceration and release from prison on HIV risk behavi
42 d practices that could mitigate the harms of incarceration and the post-incarceration period is urgen
43 ntenance-treatment clinic after release from incarceration and time to engagement with methadone main
45 ess, noninjection drug use, and a history of incarceration and/or cavitary disease were predictors of
47 access to HIV drugs, threats of violence or incarceration, and few targeted HIV prevention resources
49 n by income, reduced economic mobility, mass incarceration, and increased exposure to the costs of me
52 nsitivity predicted a higher number of prior incarcerations, and moderated the relationship between p
53 usehold substance abuse, mental illness, and incarceration; and parental domestic violence, separatio
54 sures to screen for active tuberculosis upon incarceration are important for preventing spread of dis
57 5% CI, .21-.98]; P = .044), and highest with incarceration (ARR, 1.43 [95% CI, 1.08-1.89]; P = .013)
59 buse/dependence, depression, bankruptcy, and incarceration associated with recreational gambling.
60 l was 1 day; the median length of continuous incarceration before diagnosis of tuberculosis in inmate
61 ion of networks of individuals released from incarceration, both HIV positive and negative, is needed
63 ore likely to have had four or more previous incarcerations compared with inmates who had no major ps
64 Continuation of methadone maintenance during incarceration could contribute to greater treatment enga
65 ated men, and raises concerns that excessive incarceration could harm entire communities and thus mig
66 ormer inmates, with findings suggesting that incarceration could produce some short-term improvements
67 fared the worst, with lives characterized by incarceration, criminal activity, and few positive outco
69 pants include lower pre-18-month arrests and incarceration days, treatment at baseline, not using ill
70 ys of release are intermediate (31-364 days) incarceration duration (adjusted odds ratio 1.52; 95% CI
73 ore than 600,000 prisoners are released from incarceration each year in the United States, and most e
74 demographic characteristics, and history of incarceration for the preceding 6-year period were obtai
75 with additional 9.5% urine refusal and 14.0% incarceration, for whom urinalyses were unavailable), 66
76 ry, and communities:(1) whether and how mass incarceration has affected the social and economic struc
77 waves II and IV, women experiencing parental incarceration have a 0.92-unit increase in body mass ind
78 nitiation rates are strongly associated with incarceration history, so that our analysis of IDUs' rep
80 as determined from episodes of homelessness, incarceration, hospitalization, and residence in support
81 for a sexually transmitted disease (STD) or incarceration in a prison or jail prior to their illness
82 ing for Ukraine suggests that high levels of incarceration in EECA countries facilitate HIV transmiss
84 causes of the stronger associations included incarceration increasing the number of infected prisoner
85 ndex for women who have experienced parental incarceration is 0.49 units (P < 0.004) higher than that
87 tress, the authors examined whether parental incarceration is associated with increased body mass ind
90 th of African Americans, experience parental incarceration, little research has examined links betwee
91 on to their potential for reducing crime and incarceration, may have implications for both management
92 most common criminalisation indicators were incarceration (n=38) and street-level policing (n=39), w
93 al histories containing the following HRSBs: incarceration (n=69), unprofessional tattoos or piercing
97 ect of forced withdrawal from methadone upon incarceration on individuals' risk behaviours and engage
99 and the negative influences of high rates of incarceration on social disorganization and collective e
104 risk (eg, unemployment, low income, previous incarceration, or less education) compared with other US
106 ms of the presence of negative consequences (incarceration, or readmission to compulsory treatment, o
107 er (OR, 2.68; 95% CI, 1.25-5.60), history of incarceration over 48 hours (OR, 2.56; 95% CI, 1.52-4.32
109 (P = 0.035), legal troubles (P = 0.002), and incarceration (P = 0.007) in unadjusted analyses and wit
110 ation of ART, year of discharge, duration of incarceration, parole, and AIDS Drug Assistance Program
112 gate the harms of incarceration and the post-incarceration period is urgently needed, particularly st
114 lease and reincarceration, the proportion of incarceration periods with viral suppression decreased s
115 on the family and community effects of mass incarceration points to negative health impacts on the f
116 juvenile delinquency, adult criminality, and incarceration prior to the time of spinal cord injury.
117 ses on two complementary questions regarding incarceration, prisoner reentry, and communities:(1) whe
120 ilable in prisons-despite the country's high incarceration rate and having the largest burden of peop
121 Our model indicates that decreasing the incarceration rate in people who inject drugs and provid
122 n Americans--the population with the highest incarceration rates and chlamydia burden (small communit
124 we have first to estimate piecewise constant incarceration rates in conjunction with EFR initiation r
126 tions with general population suicide rates, incarceration rates, and prison-related factors (overcro
127 use in the community, ratio of men to women, incarceration rates, and racial segregation, influence s
130 wed that forced withdrawal from methadone on incarceration reduced the likelihood of prisoners re-eng
131 he person's community supervision, length of incarceration, release type, and calendar year on the ha
134 of age, sex, race or ethnicity, whether the incarceration resulted from a violation of terms of the
135 w-up, HCV incidences per 100 person-years of incarceration risk were 1, 12, 19, and 27, respectively.
138 analysis examining if gender differences in incarceration stress response (externalizing vs. interna
139 potential for complications such as retinal incarceration, subretinal hemorrhage, and loss of vitreo
140 er educational level, poverty, homelessness, incarceration, substance use, binge alcohol use, depress
141 red by traffic incidents, criminal behavior, incarceration, suicide attempts, and comorbidities.
142 risk of serious medical and legal problems, incarceration, suicide, school difficulties and dropout,
143 treatment data collected at the time of each incarceration, the incidence of syphilis infection among
144 for 1 week at the dose at the time of their incarceration, then a tapered withdrawal regimen (for th
145 f these factors were likely present prior to incarceration, they may help medical staff identify pris
146 a pernicious "feedback" loop, in which mass incarceration undermines the structure and social organi
150 n 2004 and 2010 and tested HIV positive upon incarceration, we tested their sera using a BED HIV-1 ca
151 patients, male sex, younger age, and recent incarceration were positively associated whereas Hispani
154 ed for 74% of the decreased mortality during incarceration, while 6 causes (human immunodeficiency vi
155 ngulation within 2 years; a second had acute incarceration with bowel obstruction at 4 years, with a
157 on their methadone dose at the time of their incarceration (with dose adjustments as clinically indic
158 ting patient (0.3%) experienced acute hernia incarceration without strangulation within 2 years; a se
159 could be included in the study only if their incarceration would be more than 1 week but less than 6
160 pic before summarizing the changes that mass incarceration wrought in correctional contexts and the p
161 fferentiating the groups included history of incarceration, young age, participation in drug treatmen
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。